Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
Laura N. Burga(University of Otago), Gerburg M. Wulf(Beth Israel Deaconess Medical Center)
Cited by 84
Related Papers
Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
|Nature Communications|2020|187
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer
|Cancer Discovery|2017|76
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
|iScience|2022|35
Chromosome 12p Amplification in Triple-Negative/ <i>BRCA1-</i> Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity
|Cancer Research|2019|19
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses
|bioRxiv (Cold Spring Harbor Laboratory)|2024|3